Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors

14 Aug 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25130173
DOI: 10.1016/j.canlet.2014.08.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumorsPMID 25130173Read ↗

Decitabine: a historical review of the development of an epigenetic drugSemantic proximity Read ↗

DecitabineSemantic proximity Read ↗

The future of epigenetic therapy in solid tumours—lessons from the pastSemantic proximity Read ↗

Decitabine and its role in the treatment of hematopoietic malignanciesSemantic proximity Read ↗

Evolution of decitabine developmentSemantic proximity Read ↗

Epigenetic drugs as immunomodulators for combination therapies in solid tumorsSemantic proximity Read ↗

The cancer epigenome: Concepts, challenges, and therapeutic opportunities.Semantic proximity Read ↗

The pharmacoepigenetic paradigm in cancer treatmentSemantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategiesSemantic proximity Read ↗

In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studiesSemantic proximity Read ↗

DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implicationsSemantic proximity Read ↗

Dissection of demethylation and toxicity induced gene expression changes after decitabine treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.